Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Acq. announced
Consulting agrmnt
Appointed director
|
|
CORNERSTONE THERAPEUTICS INC (CRTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/07/2014 |
SC 13D/A
| Cornerstone BioPharma Holdings, Ltd. reports a 0% stake in Cornerstone Therapeutics Inc. |
| 02/04/2014 |
SC 13D/A
| Chiesi Farmaceutici SpA reports a 100% stake in Cornerstone Therapeutics Inc. |
| 02/04/2014 |
4
| Chiesi Farmaceutici SpA (10% Owner) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Vecchia Marco (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Stephan Robert (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Shawver Laura (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Roberts Alan (VP, Scientific Affairs) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| MCEWAN ALASTAIR STUART (CFO and Treasurer) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| McBean Kenneth (President) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Maetzel Andreas (VP, Clinical and Regulatory) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Disposed/sold 25,000 shares
@ $9.5, valued at
$237.5k
Disposed/sold 25,000 options to buy
@ $8.4, valued at
$210k
|
|
| 02/04/2014 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Disposed/sold 3,571 options to buy
@ $3.9, valued at
$13.9k
Disposed/sold 15,000 options to buy
@ $2.93, valued at
$44k
Disposed/sold 5,833 options to buy
@ $7.09, valued at
$41.4k
Disposed/sold 10,000 options to buy
@ $5.97, valued at
$59.7k
Disposed/sold 15,000 options to buy
@ $7.15, valued at
$107.3k
Disposed/sold 15,000 options to buy
@ $5.11, valued at
$76.7k
Disposed/sold 15,000 options to buy
@ $8.34, valued at
$125.1k
|
|
| 02/04/2014 |
4
| Harper James A (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Franklin Joshua B (VP, Strategy & Bus. Dev.) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Failla Anton Giorgio (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Enright Michael David (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Duarte Ira (Principal Accounting Officer) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| Collard Craig A (CEO) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/04/2014 |
4
| CODEANNE CHRISTOPHER GEORGE (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 02/03/2014 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 02/03/2014 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...|
Docs:
|
"CORNERSTONE THERAPEUTICS INC. STOCKHOLDERS APPROVE MERGER CARY, N.C., February 3, 2014 - Cornerstone Therapeutics Inc. , a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, today announced that its stockholders have approved, at a special stockholder meeting held today, the previously announced merger agreement, under which Chiesi Farmaceutici S.p.A. will acquire all of the outstanding common shares of Cornerstone for $9.50 per share in cash. Votes “FOR” the adoption of the merger agreement totaled approximately 22,541,184 shares, or 83.73% of Cornerstone's outstanding shares of common stock and entitled to vote thereon. Approximately 4,395,908 shares, or 50.22% of the shares not owned by Chiesi or any of its subsidiaries ..." |
|
| 01/31/2014 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 01/31/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/26/2013 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 12/24/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 12/13/2013 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 11/27/2013 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 11/07/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
| 11/07/2013 |
8-K
| Quarterly results |
| 10/31/2013 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 10/17/2013 |
SC 13E3
| Form SC 13E3 - Going private transaction by certain issuers: |
| 10/04/2013 |
ARS
| Form ARS - Annual Report to Security Holders |
| 10/03/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 09/17/2013 |
4
| MCEWAN ALASTAIR STUART (CFO and Treasurer) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC |
| 09/16/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
|
|